Barbara Rossetti

EmailROSSETTI.BARBARAhsrit

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Barbara Rossetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

31 Article
2 Comment/debate

Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection
Rossetti, B., Borgo, V., Emiliozzi, A., Colaneri, M., Zanelli, G., D’alessandro, M., Motta, D., Maiocchi, L., Montagnani, F., Moioli, M. C., Baiguera, C., Sambo, M., Pieri, T. C., Valsecchi, P., Bruno, R., Puoti, M. & Fabbiani, M., Jan 2022, In: Diagnostics. 12, 1, 14.
Research output: Contribution to journal › Article › peer-review

Open Access
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age
GEN-COVID Multicenter Study & GEVACOBA Study Group, Jul 1 2021, In: International Journal of Molecular Sciences. 22, 13, 6991.
Research output: Contribution to journal › Article › peer-review

Open Access
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age: International Journal of Molecular Sciences
Zanella, I., Zacchi, E., Piva, S., Filosto, M., Beligni, G., Alaverdian, D., Amitrano, S., Fava, F., Baldassarri, M., Frullanti, E., Meloni, I., Renieri, A., Castelli, F., Quiros-Roldan, E., Mari, F., Daga, S., Benetti, E., Furini, S., Fallerini, C., Valentino, F. & 163 others, Doddato, G., Giliberti, A., Tita, R., Bruttini, M., Croci, S., Pinto, A. M., Mencarelli, M. A., Rizzo, C. L., Montagnani, F., Tumbarello, M., Rancan, I., Sarno, L. D., Palmieri, M., Carriero, M. L., Fabbiani, M., Rossetti, B., Bargagli, E., Bergantini, L., D’alessandro, M., Cameli, P., Bennett, D., Anedda, F., Marcantonio, S., Scolletta, S., Franchi, F., Mazzei, M. A., Guerrini, S., Conticini, E., Cantarini, L., Frediani, B., Tacconi, D., Raffaelli, C. S., Feri, M., Donati, A., Scala, R., Guidelli, L., Spargi, G., Corridi, M., Nencioni, C., Croci, L., Caldarelli, G. P., Spagnesi, M., Piacentini, P., Bandini, M., Desanctis, E., Cappelli, S., Canac-Cini, A., Verzuri, A., Anemoli, V., Ognibene, A., Pancrazi, A., Lorubbio, M., Vaghi, M., Monforte, A. D., Miraglia, F. G., Mondelli, M. U., Bruno, R., Marco, V., Mantovani, S., Ludovisi, S., Girardis, M., Venturelli, S., Busani, S., Cossarizza, A., Antinori, A., Vergori, A., Emiliozzi, A., Rusconi, S., Siano, M., Gabrieli, A., Riva, A., Francisci, D., Schiaroli, E., Tommasi, A., Paciosi, F., Scotton, P. G., Andretta, F., Panese, S., Scaggiante, R., Gatti, F., Parisi, S. G., Antoni, M. D., Monica, M. D., Piscopo, C., Capasso, M., Russo, R., Andolfo, I., Iolascon, A., Fiorentino, G., Carella, M., Castori, M., Merla, G., Squeo, G. M., Aucella, F., Raggi, P., Marciano, C., Perna, R., Bassetti, M., Biagio, A. D., Sanguinetti, M., Masucci, L., Valente, S., Mandalà, M., Giorli, A., Salerni, L., Zucchi, P., Parravicini, P., Menatti, E., Baratti, S., Trotta, T., Giannattasio, F., Coiro, G., Lena, F., Coviello, D. A., Mussini, C., Bosio, G., Martinelli, E., Mancarella, S., Tavecchia, L., Belli, M. A., Crotti, L., Parati, G., Picchiotti, N., Gori, M., Gabbi, C., Sanarico, M., Ceri, S., Pinoli, P., Raimondi, F., Bis-Carini, F., Stella, A., Rizzi, M., Maggiolo, F., Ripamonti, D., Suardi, C., Bachetti, T., Rovere, M. T. L., Sarzi-Braga, S., Bussotti, M., Capitani, K., Zguro, K., Dei, S., Ravaglia, S., Artuso, R., Perrella, A., Bianchi, F., Bergomi, P., Catena, E., Colombo, R., Perticaroli, V., Gennarelli, M., Magri, C., Basiotto, G., Zizioli, D., Giliani, S., Monti, E., Focà, E., Carriero, C., Latronico, N., Padovani, A., Brugnoni, D., Study, GEN-COVID. M. & Group, GEVACOBA. S., 2021, In: Int. J. Mol. Sci.. 22, 13
Research output: Contribution to journal › Article › peer-review
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)
the TOCIVID-19 investigators, Italy, Dec 2021, In: Journal of Translational Medicine. 19, 1, 442.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort
for the ODOACRE Study Group, Oct 2021, In: HIV Medicine. 22, 9, p. 843-853 11 p.
Research output: Contribution to journal › Article › peer-review

Barbara Rossetti

Fingerprint

Network

Dive into details

Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection

C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age

C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age: International Journal of Molecular Sciences

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort

Barbara Rossetti

Fingerprint

Network

Research output

Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection

C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age

C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age: International Journal of Molecular Sciences

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort